Abstract
Adding Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive -bladder cancer: A randomised phase 3 trial: The BCG+MM Study (ANZUP1301)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have